View Item 

Show simple item record

Jumbled NETs promote vasculitis

dc.contributor.authorRadic, Markoen_US
dc.contributor.authorKaplan, Mariana J.en_US
dc.date.accessioned2012-11-07T17:04:27Z
dc.date.available2014-01-07T14:51:07Zen_US
dc.date.issued2012-11en_US
dc.identifier.citationRadic, Marko; Kaplan, Mariana J. (2012). "Jumbled NETs promote vasculitis." Arthritis & Rheumatism 64(11): 3498-3501. <http://hdl.handle.net/2027.42/94234>en_US
dc.identifier.issn0004-3591en_US
dc.identifier.issn1529-0131en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/94234
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.titleJumbled NETs promote vasculitisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Medical School, Ann Arboren_US
dc.contributor.affiliationotherDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, 858 Madison Avenue, Suite 211, Memphis, TN 38163en_US
dc.contributor.affiliationotherUniversity of Tennessee Health Science Center, Memphisen_US
dc.identifier.pmid22777662en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/94234/1/34615_ftp.pdf
dc.identifier.doi10.1002/art.34615en_US
dc.identifier.sourceArthritis & Rheumatismen_US
dc.identifier.citedreferenceNeeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol 2008; 180: 1895 – 902.en_US
dc.identifier.citedreferenceXiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, et al. The role of neutrophils in the induction of glomerulonephritis by anti‐myeloperoxidase antibodies. Am J Pathol 2005; 167: 39 – 45.en_US
dc.identifier.citedreferenceFalk RJ, Terrell RS, Charles LA, Jennette JC. Anti‐neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990; 87: 4115 – 9.en_US
dc.identifier.citedreferenceLittle MA, Smyth L, Salama AD, Mukherjee S, Smith J, Haskard D, et al. Experimental autoimmune vasculitis: an animal model of anti‐neutrophil cytoplasmic autoantibody‐associated systemic vasculitis. Am J Pathol 2009; 174: 1212 – 20.en_US
dc.identifier.citedreferenceCasciola‐Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317 – 30.en_US
dc.identifier.citedreferenceRadic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004; 172: 6692 – 700.en_US
dc.identifier.citedreferenceFuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176: 231 – 41.en_US
dc.identifier.citedreferenceBrinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532 – 5.en_US
dc.identifier.citedreferenceKirchner T, Moller S, Klinger M, Solbach W, Laskay T, Behnen M. The impact of various reactive oxygen species on the formation of neutrophil extracellular traps. Mediators Inflamm 2012; 2012: 849136.en_US
dc.identifier.citedreferenceKessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, et al. Netting neutrophils in autoimmune small‐vessel vasculitis. Nat Med 2009; 15: 623 – 5.en_US
dc.identifier.citedreferenceLi P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 2010; 207: 1853 – 62.en_US
dc.identifier.citedreferenceDwivedi N, Upadhyay J, Neeli I, Khan S, Pattanaik D, Myers L, et al. Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum 2012; 64: 982 – 92.en_US
dc.identifier.citedreferenceLande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, et al. Neutrophils activate plasmacytoid dendritic cells by releasing self‐DNA–peptide complexes in systemic lupus erythematosus. Sci Transl Med 2011; 3: 73ra19.en_US
dc.identifier.citedreferenceHakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 2010; 107: 9813 – 8.en_US
dc.identifier.citedreferenceVillanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011; 187: 538 – 52.en_US
dc.identifier.citedreferenceLin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, et al. Mast cells and neutrophils release IL‐17 through extracellular trap formation in psoriasis. J Immunol 2011; 187: 490 – 500.en_US
dc.identifier.citedreferenceTillack K, Breiden P, Martin R, Sospedra M. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J Immunol 2012; 188: 3150 – 9.en_US
dc.identifier.citedreferencePerry HM Jr, Schroeder HA. Syndrome simulating collagen disease caused by hydralazine (Apresoline). J Am Med Assoc 1954; 154: 670 – 3.en_US
dc.identifier.citedreferenceDeng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal–regulated kinase pathway signaling. Arthritis Rheum 2003; 48: 746 – 56.en_US
dc.identifier.citedreferenceNakazawa D, Tomaru U, Suzuki A, Masuda S, Hasegawa R, Kobayashi T, et al. Abnormal conformation and impaired degradation of propylthiouracil‐induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody– associated vasculitis. Arthritis Rheum 2012; 64: 3779 – 87.en_US
dc.identifier.citedreferenceTaurog A, Dorris ML. Myeloperoxidase‐catalyzed iodination and coupling. Arch Biochem Biophys 1992; 296: 239 – 46.en_US
dc.identifier.citedreferenceNishikawa T, Nagayama Y, Seto P, Rapoport B. Human thyroid peroxidase‐myeloperoxidase chimeric molecules: tools for the study of antigen recognition by thyroid peroxidase autoantibodies. Endocrinology 1993; 133: 2496 – 501.en_US
dc.identifier.citedreferenceLee E, Miki Y, Katsura H, Kariya K. Mechanism of inactivation of myeloperoxidase by propylthiouracil. Biochem Pharmacol 1990; 39: 1467 – 71.en_US
dc.identifier.citedreferenceAmrhein JA, Kenny FM, Ross D. Granulocytopenia, lupus‐like syndrome, and other complications of propylthiouracil therapy. J Pediatr 1970; 76: 54 – 63.en_US
dc.identifier.citedreferenceDolman KM, Gans RO, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651 – 2.en_US
dc.identifier.citedreferenceSera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 2000; 10: 595 – 9.en_US
dc.identifier.citedreferenceCsernok E, Lamprecht P, Gross WL. Clinical and immunological features of drug‐induced and infection‐induced proteinase 3‐antineutrophil cytoplasmic antibodies and myeloperoxidase‐antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol 2010; 22: 43 – 8.en_US
dc.identifier.citedreferenceXiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110: 955 – 63.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
34615_ftp.pdf
Size:
41.68KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.